Forschungsprojekte
Ergebnisse pro Seite:
50
2022 - 2025
Type-I Interferons – a double-edged sword in myeloproliferative neoplasms and chronic viral infections (SFB 1292, TP21)- Prof. Dr. MarkusRadsak,
- Dr. SabineMuth
2022 - 2026
Exploring KrasG12V-specific TCR-like CAR redirected T cells for immunotherapy in non-small cell lung cancer (NSCLC)- PD Dr. UdoHartwig
2021 - 2025
Tumorspezifische Immunisierung durch transkutane Impfung: Präklinische und klinische Entwicklung von Arzneiformen zur adjuvanten Therapie des Mantelzell-Karzinoms (SFB 1066/3, TP B18)- Prof. Dr. MarkusRadsak,
- Prof. Dr. PeterLangguth,
- Univ.-Prof. Dr. StephanGrabbe
2021 - 2040
Therapie der Myelofibrose mit KRT-232 in Kombination mit Ruxolitinib (#1262)- Prof. Dr. MarkusRadsak
2021 - 2024
Targeting chromatin complexes to reverse AML immune escape for engineered cell therapy (SFB 1292, TP 12)- Dr. MichaelKühn,
- Prof. Dr. EvelynUllrich
2021 - 2023
Utilization of the HLA-independent anti-tumor T-cell repertoire for cancer immunotherapy- Univ.-Prof. Dr. ThomasWölfel
2021 - 2023
Development and characterization of a mouse model of immuno-aging- Prof. Dr. WolframRuf,
- Dr. MichaelKühn,
- Dr. BorhaneGuezguez,
- Dr. SebastianKreiter
2020 - 2022
Understanding the mechanism of action of p53-isoforms as a potential molecular modulators of T-cell effector function- Dr. HakimEchchannaoui,
- Univ.-Prof. Dr. MatthiasTheobald
2020 - 2021
Exploring NKp44-CAR redirected T cells for adoptive immunotherapy- JuliaOberbauer,
- PD Dr. Udo F.Hartwig
2020 - 2023
Mechanistic and functional dissection of early resistance to epigenetic inhibitors in Acute Myeloid Leukemia- Dr. DanielSasca